--------------------------------------------------------------------------------
Fedora Update Notification
FEDORA-2022-5a57ca7f96
2022-05-30 04:52:42.617466
--------------------------------------------------------------------------------
Name : python-molecule
Product : Fedora 36
Version : 3.6.1
Release : 1.fc36
URL :
https://github.com/ansible/molecule
Summary : Molecule is designed to aid in the development and testing of Ansible roles
Description :
Molecule is designed to aid in the development and testing of Ansible roles.
Molecule provides support for testing with multiple instances, operating
systems and distributions, virtualization providers, test frameworks and
testing scenarios. Molecule is opinionated in order to encourage an approach
that results in consistently developed roles that are well-written, easily
understood and maintained. Molecule uses Ansible playbooks to exercise the role
and its associated tests. Molecule supports any provider that Ansible supports.
--------------------------------------------------------------------------------
Update Information:
update to version 3.6.1
--------------------------------------------------------------------------------
ChangeLog:
* Fri May 20 2022 Chedi Toueiti <chedi.toueiti(a)gmail.com> 3.6.1-1
- update to version 3.6.1-1 (#2051469)
--------------------------------------------------------------------------------
References:
[ 1 ] Bug #2051469 - python-molecule-3.6.1 is available
https://bugzilla.redhat.com/show_bug.cgi?id=2051469
--------------------------------------------------------------------------------
This update can be installed with the "dnf" update program. Use
su -c 'dnf upgrade --advisory FEDORA-2022-5a57ca7f96' at the command
line. For more information, refer to the dnf documentation available at
http://dnf.readthedocs.io/en/latest/command_ref.html#upgrade-command-label
All packages are signed with the Fedora Project GPG key. More details on the
GPG keys used by the Fedora Project can be found at
https://fedoraproject.org/keys
--------------------------------------------------------------------------------